We use both clinical and genetic information to make more accurate diagnoses. Beyond simple gene panels, we offer whole-exome and whole-genome sequencing to families where panel testing cannot identify the hereditary cause of disease. We can also provide specialty pharmacy services for some conditions.
We offer leading-edge medical and therapeutic treatments that relieve symptoms of hypertrophic cardiomyopathy, the most common form of genetic heart disease. We are working to become a Center of Excellence through the Hypertrophic Cardiomyopathy Association (HCMA), a nonprofit organization that provides support, education, advocacy and research for people with hypertrophic cardiomyopathy. A Center of Excellence (COE) is a multidisciplinary approach to care that provides expertise in a specific clinical area. Team members collaborate to provide patients with coordinated care, education, and support, including but not limited to heart failure specialists, cardiac electrophysiologists, cardiac imaging specialists, nurses, advanced practice providers, genetic counselors and supportive care specialists. This collaborative approach provides advanced treatments in hypertrophic cardiomyopathy that aims at improving quality of life and reducing the risk of hospitalization or death from hypertrophic cardiomyopathy.